#ICYMI: Local Anti–PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. https://t.co/Q6VL1RVG2f @MDAndersonNews https://t.co/d9FV9uXtut
#ICYMI: Local Anti–PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. https://t.co/QMwAQcnQ04 @MDAndersonNews https://t.co/g2nLANQCFT
RT @Rndubois: Local Anti–PD-1 Delivery Prevents Progression of #Premalignant #Lesions in a 4NQO-Oral #Carcinogenesis Mouse Model https://t.…
Local Anti–PD-1 Delivery Prevents Progression of #Premalignant #Lesions in a 4NQO-Oral #Carcinogenesis Mouse Model https://t.co/qdI8Dl0Mqt
From the August issue: Local Anti–PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. https://t.co/3DJsvCetUw @MDAndersonNews https://t.co/SqvKevCjls
Could PD-(L)1 therapy be used for premalignant lesions? A very interesting report using local anti-PD-1 delivery to prevent progression of premalignant lesions to oral cancer in a 4NQO-oral carcinogenesis mouse model. https://t.co/E0XdsJr1En
RT @siwyoung: Congratulations to Dr. Roberto Rangel and the @DrJeffreyNMyers lab at MDACC for their publication in @CAPR_AACR showing tha…
RT @siwyoung: Congratulations to Dr. Roberto Rangel and the @DrJeffreyNMyers lab at MDACC for their publication in @CAPR_AACR showing tha…
RT @siwyoung: Congratulations to Dr. Roberto Rangel and the @DrJeffreyNMyers lab at MDACC for their publication in @CAPR_AACR showing tha…
RT @rahulshethmd: Very cool use of intratumoral immunotherapy for cancer prevention! @SIO_Central
RT @siwyoung: Congratulations to Dr. Roberto Rangel and the @DrJeffreyNMyers lab at MDACC for their publication in @CAPR_AACR showing tha…
Very cool use of intratumoral immunotherapy for cancer prevention! @SIO_Central
RT @siwyoung: Congratulations to Dr. Roberto Rangel and the @DrJeffreyNMyers lab at MDACC for their publication in @CAPR_AACR showing tha…
Congratulations to Dr. Roberto Rangel and the @DrJeffreyNMyers lab at MDACC for their publication in @CAPR_AACR showing that local anti-PD1 delivery using MDP hydrogels can prevent progression of OPL lesions to oral cancer: https://t.co/OLhZs58Rjo https:
Local anti-PD-1 delivery prevents progression of premalignant lesions in a 4NQO-oral carcinogenesis mouse model https://t.co/bedYes6Sf5
Local anti-PD-1 delivery prevents progression of premalignant lesions in a 4NQO-oral carcinogenesis mouse model https://t.co/9Pm5sB7pzN